274 related articles for article (PubMed ID: 20583438)
21. Autoimmune cholangitis with features of autoimmune hepatitis: successful treatment with immunosuppressive agents and ursodeoxycholic acid.
Li CP; Tong MJ; Hwang SJ; Luo JC; Co RL; Tsay SH; Chang FY; Lee SD
J Gastroenterol Hepatol; 2000 Jan; 15(1):95-8. PubMed ID: 10719755
[TBL] [Abstract][Full Text] [Related]
22. Autoimmune hepatitis 2 years after the diagnosis of primary sclerosing cholangitis: an unusual overlap syndrome in a 17-year-old adolescent.
Mueller T; Bianchi L; Menges M
Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):232-6. PubMed ID: 18301306
[TBL] [Abstract][Full Text] [Related]
23. Overlap syndromes.
Beuers U; Rust C
Semin Liver Dis; 2005 Aug; 25(3):311-20. PubMed ID: 16143946
[TBL] [Abstract][Full Text] [Related]
24. Long term outcome and response to therapy of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
Chazouillères O; Wendum D; Serfaty L; Rosmorduc O; Poupon R
J Hepatol; 2006 Feb; 44(2):400-6. PubMed ID: 16356577
[TBL] [Abstract][Full Text] [Related]
25. [Autoimmune hepatitis: new diagnostic and therapeutic approach].
Prelipcean CC; Mihai C; Stefănescu C; Drug VL
Rev Med Chir Soc Med Nat Iasi; 2004; 108(1):32-9. PubMed ID: 15688753
[TBL] [Abstract][Full Text] [Related]
26. Deflazacort for type-1 autoimmune hepatitis in a Korean girl.
Bae SH; Kim JS; Kim DH
J Korean Med Sci; 2006 Aug; 21(4):758-60. PubMed ID: 16891827
[TBL] [Abstract][Full Text] [Related]
27. Overlap of primary biliary cirrhosis and autoimmune hepatitis: Characteristics, therapy, and long term outcomes.
Yokokawa J; Saito H; Kanno Y; Honma F; Monoe K; Sakamoto N; Abe K; Takahashi A; Yokokawa H; Ohira H
J Gastroenterol Hepatol; 2010 Feb; 25(2):376-82. PubMed ID: 19817953
[TBL] [Abstract][Full Text] [Related]
28. Autoimmune liver disease. Current standards, future directions.
Gish RG; Mason A
Clin Liver Dis; 2001 May; 5(2):287-314. PubMed ID: 11385965
[TBL] [Abstract][Full Text] [Related]
29. Persistent elevation of serum alanine aminotransferase levels leads to poor survival and hepatocellular carcinoma development in type 1 autoimmune hepatitis.
Miyake Y; Iwasaki Y; Terada R; Okamaoto R; Ikeda H; Makino Y; Kobashi H; Takaguchi K; Sakaguchi K; Shiratori Y
Aliment Pharmacol Ther; 2006 Oct; 24(8):1197-205. PubMed ID: 17014578
[TBL] [Abstract][Full Text] [Related]
30. Treatment of autoimmune hepatitis.
Czaja AJ
Semin Liver Dis; 2002 Nov; 22(4):365-78. PubMed ID: 12447708
[TBL] [Abstract][Full Text] [Related]
31. [Autoimmune cholestasis syndrome. Ursodeoxycholic acid is the drug standard].
Stiefelhagen P
MMW Fortschr Med; 2007 May; 149(21):49. PubMed ID: 17668736
[No Abstract] [Full Text] [Related]
32. [Autoimmune hepatitis caused by acute hepatitis due to hepatitis A virus].
Muñoz Bertrán E; Rosa Salazar V; Hostalet Robles F; Correa Estañ JA; Belda Abad G; Muñoz Ramírez E
Gastroenterol Hepatol; 2002 Oct; 25(8):501-4. PubMed ID: 12361532
[TBL] [Abstract][Full Text] [Related]
33. [Therapy of chronic hepatitis].
Dioguardi N
Minerva Med; 1974 Nov; 65(82):4261-6. PubMed ID: 4431580
[No Abstract] [Full Text] [Related]
34. [Diagnosis and treatment of autoimmune hepatitis].
Verwer BJ; Bouma G; Bloemena E; Schreuder TC; Mulder CJ; van Nieuwkerk KM
Ned Tijdschr Geneeskd; 2009; 153():A247. PubMed ID: 19900315
[TBL] [Abstract][Full Text] [Related]
35. Long-term management and prognosis of autoimmune hepatitis (AIH): a single center experience.
Kanzler S; Löhr H; Gerken G; Galle PR; Lohse AW
Z Gastroenterol; 2001 May; 39(5):339-41, 344-8. PubMed ID: 11413913
[TBL] [Abstract][Full Text] [Related]
36. Combination of steroid with azathioprine in treatment of giant cell autoimmune hepatitis.
Eroğlu Y; Düzovali O; Kavukçu S; Irken G; Büyükgebiz B
Turk J Pediatr; 1997; 39(4):565-71. PubMed ID: 9433162
[TBL] [Abstract][Full Text] [Related]
37. Presence of antimitochondrial autoantibodies in patients with autoimmune hepatitis.
Nezu S; Tanaka A; Yasui H; Imamura M; Nakajima H; Ishida H; Takahashi S
J Gastroenterol Hepatol; 2006 Sep; 21(9):1448-54. PubMed ID: 16911691
[TBL] [Abstract][Full Text] [Related]
38. Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid.
Joshi S; Cauch-Dudek K; Wanless IR; Lindor KD; Jorgensen R; Batts K; Heathcote EJ
Hepatology; 2002 Feb; 35(2):409-13. PubMed ID: 11826416
[TBL] [Abstract][Full Text] [Related]
39. [Autoimmune hepatitis: recent update on diagnosis and treatment].
Lee YS
Korean J Hepatol; 2006 Sep; 12(3):318-32. PubMed ID: 16998286
[TBL] [Abstract][Full Text] [Related]
40. IgG4-related Autoimmune Hepatitis with a Suspected Drug-induced Etiology.
Kawabata H; Kawakatsu Y; Inoue N; Okazaki Y; Sone D; Yamaguchi K; Ueda Y; Hitomi M; Miyata M; Motoi S; Enoki Y; Minamikawa T
Intern Med; 2020; 59(11):1401-1405. PubMed ID: 32475907
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
